Overview

The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers

Status:
Recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study to evaluate changes in comfort and dryness in symptomatic contact lens (CL) wearers after using Xiidra (lifitegrast 5.0% ophthalmic solution) for 12 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
University of Waterloo
Collaborator:
Novartis
Treatments:
Lifitegrast